Follow this preprint
AI coupled to pharmacometric modelling to tailor malaria and tuberculosis treatment in Africa
View ORCID ProfileGemma Turon, View ORCID ProfileMwila Mulubwa, Anna Montaner, View ORCID ProfileMathew Njoroge, View ORCID ProfileKelly Chibale, View ORCID ProfileMiquel Duran-Frigola
doi: https://doi.org/10.1101/2024.11.07.24316884
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Gemma Turon
1Ersilia Open Source Initiative, Barcelona, Spain
Mwila Mulubwa
2Holistic Drug Discovery and Development (H3D) Centre, South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Anna Montaner
1Ersilia Open Source Initiative, Barcelona, Spain
Mathew Njoroge
2Holistic Drug Discovery and Development (H3D) Centre, South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Kelly Chibale
2Holistic Drug Discovery and Development (H3D) Centre, South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Miquel Duran-Frigola
1Ersilia Open Source Initiative, Barcelona, Spain
Data availability
All PGx data used in the study has been curated from the publicly available resource PharmGKB, accessed in January, 2024. Curated data is available in the https://github.com/ersilia-os/pharmacogx-embeddings. Data related to genomic variants has been curated from the 1000 Genomes project and is available in https://github.com/ersilia-os/pharmacogx-arsa.
Posted November 07, 2024.
AI coupled to pharmacometric modelling to tailor malaria and tuberculosis treatment in Africa
Gemma Turon, Mwila Mulubwa, Anna Montaner, Mathew Njoroge, Kelly Chibale, Miquel Duran-Frigola
medRxiv 2024.11.07.24316884; doi: https://doi.org/10.1101/2024.11.07.24316884
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2918)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12711)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4567)
- Geriatric Medicine (415)
- Health Economics (726)
- Health Informatics (2913)
- Health Policy (1068)
- Hematology (386)
- HIV/AIDS (922)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (467)
- Neurology (4335)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (499)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6916)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (383)
- Surgery (486)
- Toxicology (60)
- Transplantation (210)
- Urology (178)